Rational Fluid Therapy in Germany (RaFTinG)

July 7, 2011 updated by: Ludwig-Maximilians - University of Munich

Klinisches Register RaFTinG - Rational Fluid Therapy in Germany

The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

Study Overview

Status

Unknown

Conditions

Detailed Description

The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany.

Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.

Study Type

Observational

Enrollment (Anticipated)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • Bavaria
      • Munich, Bavaria, Germany, 80336
        • Klinik für Anaesthesiologie, Klinikum der Universität München
    • Nordrhein - Westfalen
      • Münster, Nordrhein - Westfalen, Germany, 48149
        • Universitatsklinikum Munster

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients in intensive care units with an indication for fluid/volume therapy

Description

Inclusion Criteria:

  • ICU patients with an indication for fluid/volume therapy

Exclusion Criteria:

  • Patients hospitalized by order of a court of law or a government agency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ludwig-Maximilians - University of Munich

Collaborators

University Hospital Muenster
Fresenius Kabi, Bad Homburg, Germany

Investigators

  • Principal Investigator: Matthias Jacob, MD, Klinik für Anaesthesiologie, Klinikum der Universität München
  • Principal Investigator: Christian Ertmer, MD, Universitätsklinikum Münster, Germany
  • Study Chair: Bernhard Zwissler, Prof, Klinik für Anaesthesiologie, Klinikum der Universität München, Germany
  • Study Chair: Hugo van Aken, Prof, Universitätsklinikum Münster, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Actual)

May 1, 2011

Study Completion (Anticipated)

October 1, 2011

Study Registration Dates

First Submitted

May 11, 2010

First Submitted That Met QC Criteria

May 12, 2010

First Posted (Estimate)

May 13, 2010

Study Record Updates

Last Update Posted (Estimate)

July 8, 2011

Last Update Submitted That Met QC Criteria

July 7, 2011

Last Verified

October 1, 2010

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 337 -09/2009-366-f-S

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients in ICU

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe